Stockscreener 앱 받기
19.53
2.14%
0.41
시간 외 거래:
19.53
전일 마감가:
$19.12
열려 있는:
$18.86
하루 거래량:
315.79K
Relative Volume:
0.78
시가총액:
$943.30M
수익:
$96.21M
순이익/손실:
$-12.13M
주가수익비율:
-62.40
EPS:
-0.313
순현금흐름:
$10.64M
1주 성능:
+7.60%
1개월 성능:
-15.93%
6개월 성능:
-23.62%
1년 성능:
-23.35%
1일 변동 폭
$18.86
$19.79
1주일 범위
$17.86
$19.79
52주 변동 폭
$17.86
$29.62
바이오라이프 솔루션즈 Stock (BLFS) Company Profile
명칭
Biolife Solutions Inc
전화
(425) 401-1400
주소
3303 MONTE VILLA PARKWAY, BOTHELL, WA
Compare BLFS vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BLFS
Biolife Solutions Inc
|
19.53 | 923.50M | 96.21M | -12.13M | 10.64M | -0.313 |
|
ISRG
Intuitive Surgical Inc
|
479.93 | 169.66B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
156.53 | 44.97B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
75.01 | 36.92B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
43.59 | 34.30B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
227.41 | 33.20B | 5.40B | 1.49B | 1.78B | 10.12 |
바이오라이프 솔루션즈 Stock (BLFS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-22 | 재개 | Stephens | Overweight |
| 2024-09-30 | 개시 | H.C. Wainwright | Buy |
| 2024-04-04 | 개시 | Jefferies | Buy |
| 2023-07-11 | 개시 | Craig Hallum | Buy |
| 2022-04-25 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-10-19 | 개시 | B. Riley Securities | Buy |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-05-14 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2021-03-23 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-09-22 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-09-18 | 개시 | Cowen | Outperform |
| 2020-08-11 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2020-07-08 | 재확인 | Maxim Group | Buy |
| 2020-02-24 | 개시 | Lake Street | Buy |
| 2020-02-19 | 개시 | The Benchmark Company | Buy |
| 2020-02-06 | 재개 | B. Riley FBR | Buy |
| 2020-01-08 | 개시 | Stephens | Overweight |
| 2019-11-21 | 개시 | Oppenheimer | Outperform |
| 2019-07-22 | 개시 | H.C. Wainwright | Buy |
| 2017-11-10 | 재확인 | Maxim Group | Buy |
| 2017-09-19 | 재확인 | Maxim Group | Buy |
| 2017-07-05 | 업그레이드 | Janney | Neutral → Buy |
| 2017-03-10 | 재확인 | Maxim Group | Buy |
| 2017-01-19 | 개시 | Maxim Group | Buy |
모두보기
바이오라이프 솔루션즈 주식(BLFS)의 최신 뉴스
BioLife Solutions, Inc. (BLFS) surpasses Q4 earnings and revenue estimates - MSN
Wall Street Analysts Believe BioLife Solutions (BLFS) Could Rally 35%: Here's is How to Trade - MSN
Is BioLife Solutions Inc. a cyclical or defensive stockMarket Growth Review & Daily Volume Surge Trade Alerts - mfd.ru
BioLife Solutions Earnings Call Signals Profitable Growth - TipRanks
BioLife Solutions, Inc. $BLFS is Casdin Capital LLC's 2nd Largest Position - MarketBeat
Analysts Are Bullish on Top Healthcare Stocks: Acurx Pharmaceuticals (ACXP), BioLife Solutions (BLFS) - The Globe and Mail
BLFSBiolife Solutions Inc Latest Stock News & Market Updates - Stock Titan
After Plunging 17.6% in 4 Weeks, Here's Why the Trend Might Reverse for BioLife Solutions (BLFS) - Yahoo Finance
BioLife Solutions (NASDAQ:BLFS) Hits New 1-Year Low on Insider Selling - MarketBeat
Insider Sell: Karen Foster Sells 97,423 Shares of BioLife Soluti - GuruFocus
Karen Foster Sells 96,923 Shares of BioLife Solutions (NASDAQ:BLFS) Stock - MarketBeat
BioLife Solutions Officer Sells Shares - TradingView
BioLife Solutions (NASDAQ: BLFS) officer sells 97K shares in open market - Stock Titan
Insider sells 500 shares at BioLife Solutions (NASDAQ: BLFS) amid recent 10b5-1 trades - Stock Titan
Volatility Watch: What is C4 Therapeutics Incs valuation compared to sector2026 Earnings & Precise Swing Trade Alerts - baoquankhu1.vn
BioLife Solutions, Inc. $BLFS Shares Purchased by Vanguard Group Inc. - MarketBeat
Wall Street Analysts Predict a 39.92% Upside in BioLife Solutions (BLFS): Here's What You Should Know - MSN
BioLife Solutions Hits Day High with Strong 7.65% Intraday Surge - Markets Mojo
Cramer Rosenthal Mcglynn LLC Decreases Stock Position in BioLife Solutions, Inc. $BLFS - MarketBeat
BioLife Solutions (NASDAQ:BLFS) EVP Aby Mathew Sells 529 Shares - MarketBeat
Troy Wichterman Sells 588 Shares of BioLife Solutions (NASDAQ:BLFS) Stock - MarketBeat
BioLife Solutions (BLFS) EVP sells 529 shares via 10b5-1 tax plan - Stock Titan
BLFS SEC FilingsBiolife Solutions Inc 10-K, 10-Q, 8-K Forms - Stock Titan
BioLife Solutions (BLFS) -10%: Stock Drops on ‘Sell the News’ Reaction to Strong Guidance - Trefis
BioLife Solutions (BLFS) -10%: Stock Drops on 'Sell the News' Reaction to Strong Guidance - Trefis
A Look At BioLife Solutions (BLFS) Valuation After Earnings Beat And 2026 Growth Guidance - simplywall.st
BioLife Solutions (NASDAQ:BLFS) Stock Price Down 11.2%Time to Sell? - MarketBeat
BioLife Solutions, Inc. (BLFS) Stock Analysis: 43.87% Potential Upside Captures Investor Attention - DirectorsTalk Interviews
BioLife Solutions, Inc. $BLFS Shares Sold by Royce & Associates LP - MarketBeat
BioLife Solutions Highlights Growth and Strategic Refocus in Presentation - TipRanks
BioLife Solutions issues investor presentation highlighting FY2025 results and 2026 guidance - TradingView
BioLife Solutions (BLFS) details 2025 surge and 2026 profit outlook - Stock Titan
Does BioLife’s 2026 Profitability Guidance and Media Strength Change The Bull Case For BLFS? - simplywall.st
FY2026 EPS Estimates for BLFS Increased by Analyst - MarketBeat
Should BioLife Solutions’ 2026 Profitability Guidance and Refocus Require Action From BLFS Investors? - Yahoo Finance
BLFS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BioLife Solutions (NASDAQ:BLFS) Raised to Buy at Wall Street Zen - MarketBeat
BLFS PE Ratio & Valuation, Is BLFS Overvalued - Intellectia AI
BioLife Solutions (NASDAQ:BLFS) Shares Gap UpWhat's Next? - MarketBeat
Can BioLife Solutions Capitalize On The Explosive Growth Of The Cell And Gene Therapy Market? - RTTNews
BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2025 Earnings Call Transcript - Insider Monkey
Analysts Have Conflicting Sentiments on These Healthcare Companies: Phathom Pharmaceuticals (PHAT), BioLife Solutions (BLFS) and RxSight (RXST) - The Globe and Mail
BioLife Solutions earnings beat by $0.23, revenue topped estimates - Investing.com Canada
Beyond the Balance Sheet: What SWOT Reveals About BioLife Soluti - GuruFocus
BioLife Solutions Inc (BLFS) Q4 2025 Earnings Call Highlights: S - GuruFocus
BioLife Solutions, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Earnings call transcript: BioLife Solutions Q4 2025 earnings beat expectations - Investing.com Nigeria
BioLife Solutions Inc reports results for the quarter ended September 30Earnings Summary - TradingView
BioLife Solutions (BLFS) director receives 8,170-share stock grant - Stock Titan
BioLife Solutions, Inc. (BLFS) Surpasses Q4 Earnings and Revenue Estimates - Yahoo Finance
BioLife Solutions (NASDAQ: BLFS) exec reports stock grant and tax withholding - Stock Titan
바이오라이프 솔루션즈 (BLFS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.06%
0.65%
자본화:
|
볼륨(24시간):